Retinopathy and Nephropathy in Patients with Type 1 Diabetes Four Years after a Trial of Intensive Therapy

Abstract

The reduction in the risk of progressive retinopathy and nephropathy resulting from intensive therapy in patients with type 1 diabetes persists for at least four years, despite increasing hyperglycemia.

Keywords

MedicineRetinopathyNephropathyDiabetic retinopathyDiabetes mellitusSurgeryIntensive careInternal medicineOdds ratioIntensive care medicineEndocrinology

MeSH Terms

AdolescentAdultDiabetes MellitusType 1Diabetic NephropathiesDiabetic RetinopathyDisease ProgressionFemaleFollow-Up StudiesGlycated HemoglobinHumansIncidenceInsulinMaleRandomized Controlled Trials as TopicRegression AnalysisRiskSeverity of Illness Index

Related Publications

Prevalence of Complications Among Second-Generation Japanese-American Men With Diabetes, Impaired Glucose Tolerance, or Normal Glucose Tolerance

Wilfred Y. Fujimoto , Donna L. Leonetti , James L. Kinyoun +3 more

In a study sample of 229 second-generation Japanese- American (Nisei) men, 79 with normal glucose tolerance, 72 with impaired glucose tolerance (IGT), and 78 with non-insulin-de...

1987 Diabetes 128 citations

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

Vlado Perkovic , Meg Jardine , Bruce Neal +21 more

In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a med...

2019 New England Journal of Medicine 5513 citations

Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

R B Sleight , Peter Sleight , Sarah Parish +3 more

17,187 patients entering 417 hospitals up to 24 hours (median 5 hours) after the onset of suspected acute myocardial infarction were randomised, with placebo control, between: (...

1988 PubMed 2873 citations

Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus

K. Malmberg

Insulin-glucose infusion followed by intensive subcutaneous insulin in diabetic patients with acute myocardial infarction improves long term survival, and the effect seen at one...

1997 BMJ 1299 citations

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Melanie J. Davies , David A. D’Alessio , Judith Fradkin +7 more

The American Diabetes Association and the European Association for the Study of Diabetes convened a panel to update the prior position statements, published in 2012 and 2015, on...

2018 Diabetes Care 3378 citations

Publication Info

Year: 2000
Type: article
Volume: 342
Issue: 6
Pages: 381-389
Citations: 1523
Access: Closed

External Links

Download PDF (Free) View on DOI.org PubMed Semantic Scholar

Social Impact

Altmetric

Retinopathy and Nephropathy in Patients with Type 1 Diabetes Four Years after a Trial of Intensive Therapy

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1523

OpenAlex

Influential

1191

CrossRef

Cite This

APA Style

                            
                                
                                    John M. Lachin, 
                                
                                    Saul Genuth, 
                                
                                    Patricia A. Cleary
                                
                                et al.
                            
                            (2000). 
                            Retinopathy and Nephropathy in Patients with Type 1 Diabetes Four Years after a Trial of Intensive Therapy. 
                            New England Journal of Medicine
                            , 342
                            (6)
                            , 381-389.
                            https://doi.org/10.1056/nejm200002103420603
                        

Identifiers

DOI: 10.1056/nejm200002103420603
PMID: 10666428
PMCID: PMC2630213

Data Quality

Data completeness: 86%